Market competition does not exist in the U.S. healthcare system. Health insurers’ provider networks contractually protect medical groups and hospitals from competing with one another on price. Government policy coupled with a crowded distribution channel enable drug manufacturers to control their own pricing in the U.S. Without price transparency, economic and consumer benefits of market competition cannot exist.
top of page
bottom of page